Literature DB >> 15317740

Using computer technology to detect, measure, and prevent adverse drug events.

Reed M Gardner, R Scott Evans.   

Abstract

Mesh：

Year:  2004        PMID： 15317740      PMCID： PMC524634          DOI： 10.1197/jamia.M1651

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN： 1067-5027            Impact factor:   4.497


× No keyword cloud information.
  8 in total

1.  Medication safety: moving from illusion to reality.

Authors:  David Classen
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

2.  Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting.

Authors:  Jonathan R Nebeker; Paul Barach; Matthew H Samore
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

3.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

4.  Evaluation of user acceptance of a clinical expert system.

Authors:  R M Gardner; H P Lundsgaarde
Journal:  J Am Med Inform Assoc       Date:  1994 Nov-Dec       Impact factor: 4.497

5.  Strategies for detecting adverse drug events among older persons in the ambulatory setting.

Authors:  Terry S Field; Jerry H Gurwitz; Leslie R Harrold; Jeffrey M Rothschild; Kristin Debellis; Andrew C Seger; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2004-08-06       Impact factor: 4.497

6.  Computerized medication monitoring system.

Authors:  R K Hulse; S J Clark; J C Jackson; H R Warner; R M Gardner
Journal:  Am J Hosp Pharm       Date:  1976-10

7.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

8.  Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system.

Authors:  Tyken C Hsieh; Gilad J Kuperman; Tonushree Jaggi; Patricia Hojnowski-Diaz; Julie Fiskio; Deborah H Williams; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2004-08-06       Impact factor: 4.497
  8 in total
  11 in total

1.  Implementing a commercial rule base as a medication order safety net.

Authors:  Richard M Reichley; Terry L Seaton; Ervina Resetar; Scott T Micek; Karen L Scott; Victoria J Fraser; W Claiborne Dunagan; Thomas C Bailey
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

2.  Effect of CPOE user interface design on user-initiated access to educational and patient information during clinical care.

Authors:  S Trent Rosenbloom; Antoine J Geissbuhler; William D Dupont; Dario A Giuse; Douglas A Talbert; William M Tierney; W Dale Plummer; William W Stead; Randolph A Miller
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

3.  Clinical decision support and electronic prescribing systems: a time for responsible thought and action.

Authors:  Randolph A Miller; Reed M Gardner; Kevin B Johnson; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2005-05-19       Impact factor: 4.497

4.  Overriding of drug safety alerts in computerized physician order entry.

Authors:  Heleen van der Sijs; Jos Aarts; Arnold Vulto; Marc Berg
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

5.  Strategies for reducing nuisance alerts in a dose checking application.

Authors:  Ervina Resetar; Richard M Reichley; Laura A Noirot; Joshua A Doherty; Wm C Dunagan; Thomas C Bailey
Journal:  AMIA Annu Symp Proc       Date:  2005

6.  Development and validation of a survey instrument for assessing prescribers' perception of computerized drug-drug interaction alerts.

Authors:  Kai Zheng; Kathleen Fear; Bruce W Chaffee; Christopher R Zimmerman; Edward M Karls; Justin D Gatwood; James G Stevenson; Mark D Pearlman
Journal:  J Am Med Inform Assoc       Date:  2011-04-12       Impact factor: 4.497

7.  Consensus building for development of outpatient adverse drug event triggers.

Authors:  Hillary J Mull; Jonathan R Nebeker; Stephanie L Shimada; Haytham M A Kaafarani; Peter E Rivard; Amy K Rosen
Journal:  J Patient Saf       Date:  2011-06       Impact factor: 2.844

8.  Recommendations for selecting drug-drug interactions for clinical decision support.

Authors:  Hugh Tilson; Lisa E Hines; Gerald McEvoy; David M Weinstein; Philip D Hansten; Karl Matuszewski; Marianne le Comte; Stefanie Higby-Baker; Joseph T Hanlon; Lynn Pezzullo; Kathleen Vieson; Amy L Helwig; Shiew-Mei Huang; Anthony Perre; David W Bates; John Poikonen; Michael A Wittie; Amy J Grizzle; Mary Brown; Daniel C Malone
Journal:  Am J Health Syst Pharm       Date:  2016-04-15       Impact factor: 2.637

9.  Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.

Authors:  Tesfahun Chanie Eshetie; Bisrat Hailemeskel; Negussu Mekonnen; Getahun Paulos; Alemayehu Berhane Mekonnen; Tsinuel Girma
Journal:  BMC Pediatr       Date:  2015-07-15       Impact factor: 2.125

10.  Assessing the potential adoption and usefulness of concurrent, action-oriented, electronic adverse drug event triggers designed for the outpatient setting.

Authors:  Hillary J Mull; Amy K Rosen; Stephanie L Shimada; Peter E Rivard; Brian Nordberg; Brenna Long; Jennifer M Hoffman; Molly Leecaster; Lucy A Savitz; Christopher W Shanahan; Amy Helwig; Jonathan R Nebeker
Journal:  EGEMS (Wash DC)       Date:  2015-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.